U
CCXI

UBS’s ChemoCentryx, Inc. CCXI Stock Holding History

UBS’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,000
Closed -$28K – 10879
2013
Q3 		$28K Buy
+5,000
New +$54.1K ﹤0.01% 7638

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

UBS's CCXI Position: Q3 2014 in Review

UBS increased its ChemoCentryx, Inc. (CCXI) stake by 87% in Q3 2014, buying an estimated $3.02K and bringing the position to 1,229 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #9330.

UBS first reported a position in CCXI in Q4 2013 and has held it in 4 quarters since. The position peaked at $13K in Q4 2013. 64 funds tracked by Wall St. Rank hold CCXI as of Q3 2014.

  • UBS held 1,229 shares of ChemoCentryx, Inc. worth $6K as of Q3 2014.
  • UBS bought 572 ChemoCentryx, Inc. shares in Q3 2014, an estimated $3.02K.
  • ChemoCentryx, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9330 holding.
  • UBS first reported a position in ChemoCentryx, Inc. in Q4 2013 and has held it in 4 quarters since.
  • UBS's ChemoCentryx, Inc. position peaked at $13K in Q4 2013.
  • 64 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.